A judge has rejected a bid by a group of Apache Corporation companies to break up a looming trial in a long-running dispute with WA-based oil and gas company Santos, saying holding a hearing on separate issues would not be the time saver Apache claims.
The judge overseeing the lengthy trial between agricultural giants Cargill and Viterra over the $420 million sale of malt producer Joe White has shot down Viterra’s request to shield the identity of malting companies that allegedly engaged in shady business practices, including using a banned substance to produce malt.
AMP will challenge the admissibility of an expert report central to ASIC’s case over alleged insurance churning by one of the wealth manager’s former financial advisers, after a judge called on the regulator to be more transparent about its communication with the experts in the case.
Trader Daniel Schlaepfer and his firm Select Vantage were alerted to possible market manipulation and flaws in the company’s surveillance system, the court has heard mid-trial in the case alleging ASIC made defamatory remarks to the trading firm’s major business partners.
Trader Daniel Schlaepfer and his firm Select Vantage are seeking over $10 million in damages from the Australian Securities and Investments Commission in a defamation action against the corporate regulator, a court heard Thursday on the fourth day of trial in the case.
The Australian Securities and Investments Commission made global trading firm Select Vantage “vanish overnight” from the Australian market using slanderous statements based on a lack of evidence, the NSW Supreme Court has heard.
The trial in a much anticipated shareholder class action against engineering firm WorleyParsons scheduled to commence this week has hit a roadblock, with a last minute change in the judge that will hear the matter.
The stakes will be high for the ACCC when the trial kicks off Monday in its case against Ramsay Health Care alleging the hospital giant misused its market power and engaged in exclusive dealing, after the competition regulator came up short in its last big misuse of market power case against pharmaceutical giant Pfizer.
The judge overseeing the marathon trial between agricultural giants Cargill and Viterra over the $420 million sale of malt producer Joe White has shot down objections to both parties’ expert reports related to whether it was common industry practice to cheat customers by failing to comply with contract details and providing misleading malt test results.
Viterra can amend its defence mid-trial in its dispute with Cargill over the $420 sale of its Joe White malt business to argue it was standard industry practice to fudge test results relating to malt quality, provided it identifies which industry players engaged in the practice.